Leiden Dworak
Comptroller/Controller/Auditor at TSCAN THERAPEUTICS, INC.
Net worth: 48 667 $ as of 30/05/2024
Leiden Dworak active positions
| Companies | Position | Start | End |
|---|---|---|---|
| TSCAN THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 20/07/2023 | - |
| Corporate Officer/Principal | 10/04/2022 | 20/07/2023 |
Career history of Leiden Dworak
Former positions of Leiden Dworak
| Companies | Position | Start | End |
|---|---|---|---|
| MODERNA, INC. | Director/Board Member | - | - |
| TECTONIC THERAPEUTIC, INC. | Corporate Officer/Principal | - | - |
Training of Leiden Dworak
| Indiana University | Masters Business Admin |
Statistics
International
| United States | 5 |
Operational
| Corporate Officer/Principal | 2 |
| Comptroller/Controller/Auditor | 1 |
| Masters Business Admin | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| TSCAN THERAPEUTICS, INC. | Health Technology |
| MODERNA, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Avrobio, Inc.
 Avrobio, Inc. BiotechnologyHealth Technology AVROBIO, Inc. engages in the development of lentiviral-based gene therapies. It focuses on developing potentially curative ex vivo lentiviral-based gene therapies to treat patients with rare diseases following a single dose treatment regimen. The firm's clinical-stage programs include Fabry, Gaucher Type 1, Hunter syndrome Gaucher Type 3, Pompe, and Cystinosis. The company was founded by Geoff Mackay, Kim Warren, Christopher Mason, and Jeffrey Medin in 2015 and is headquartered in Watertown, MA. | Health Technology |
- Stock Market
- Insiders
- Leiden Dworak
- Experience
